XBIOTECH INC. Payments to Acquire Restricted Certificates of Deposit
XBIOTECH INC. (XBIT) reported Payments to Acquire Restricted Certificates of Deposit of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireRestrictedCertificatesOfDeposit · last filed 2023-11-09
- XBIOTECH INC. payments to acquire restricted certificates of deposit for the quarter ending 2022-12-31 was $3.77M.
- XBIOTECH INC. payments to acquire restricted certificates of deposit for the quarter ending 2021-12-31 was $0.00.
- XBIOTECH INC. payments to acquire restricted certificates of deposit for fiscal 2022 was $63.31M.
- XBIOTECH INC. payments to acquire restricted certificates of deposit for fiscal 2021 was $0.00.
| Period end | Payments to Acquire Restricted Certificates of Deposit 3 month | Payments to Acquire Restricted Certificates of Deposit 9 month | Payments to Acquire Restricted Certificates of Deposit 12 month |
|---|---|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-09 | ||
| 2022-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $63.31M 10-K · filed 2023-03-15 | |
| 2022-09-30 | $59.53M 10-Q · filed 2023-11-09 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |